PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DHR vs. ABT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DHR and ABT is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

DHR vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Danaher Corporation (DHR) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-22.19%
19.99%
DHR
ABT

Key characteristics

Sharpe Ratio

DHR:

-0.69

ABT:

1.00

Sortino Ratio

DHR:

-0.84

ABT:

1.58

Omega Ratio

DHR:

0.89

ABT:

1.19

Calmar Ratio

DHR:

-0.54

ABT:

0.75

Martin Ratio

DHR:

-1.56

ABT:

2.36

Ulcer Index

DHR:

10.58%

ABT:

8.14%

Daily Std Dev

DHR:

23.83%

ABT:

19.13%

Max Drawdown

DHR:

-65.35%

ABT:

-45.66%

Current Drawdown

DHR:

-28.45%

ABT:

0.00%

Fundamentals

Market Cap

DHR:

$147.40B

ABT:

$229.17B

EPS

DHR:

$5.29

ABT:

$7.64

PE Ratio

DHR:

38.75

ABT:

17.29

PEG Ratio

DHR:

3.85

ABT:

2.34

Total Revenue (TTM)

DHR:

$23.88B

ABT:

$30.98B

Gross Profit (TTM)

DHR:

$14.21B

ABT:

$17.29B

EBITDA (TTM)

DHR:

$6.75B

ABT:

$7.89B

Returns By Period

In the year-to-date period, DHR achieves a -9.41% return, which is significantly lower than ABT's 18.35% return. Over the past 10 years, DHR has outperformed ABT with an annualized return of 19.38%, while ABT has yielded a comparatively lower 13.07% annualized return.


DHR

YTD

-9.41%

1M

-14.81%

6M

-22.19%

1Y

-16.68%

5Y*

8.15%

10Y*

19.38%

ABT

YTD

18.35%

1M

14.03%

6M

19.99%

1Y

15.29%

5Y*

10.75%

10Y*

13.07%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DHR vs. ABT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DHR
The Risk-Adjusted Performance Rank of DHR is 1212
Overall Rank
The Sharpe Ratio Rank of DHR is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of DHR is 1313
Sortino Ratio Rank
The Omega Ratio Rank of DHR is 1313
Omega Ratio Rank
The Calmar Ratio Rank of DHR is 1515
Calmar Ratio Rank
The Martin Ratio Rank of DHR is 44
Martin Ratio Rank

ABT
The Risk-Adjusted Performance Rank of ABT is 7272
Overall Rank
The Sharpe Ratio Rank of ABT is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of ABT is 7272
Sortino Ratio Rank
The Omega Ratio Rank of ABT is 6969
Omega Ratio Rank
The Calmar Ratio Rank of ABT is 7474
Calmar Ratio Rank
The Martin Ratio Rank of ABT is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DHR vs. ABT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Danaher Corporation (DHR) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DHR, currently valued at -0.69, compared to the broader market-2.000.002.00-0.691.00
The chart of Sortino ratio for DHR, currently valued at -0.84, compared to the broader market-4.00-2.000.002.004.006.00-0.841.58
The chart of Omega ratio for DHR, currently valued at 0.89, compared to the broader market0.501.001.502.000.891.19
The chart of Calmar ratio for DHR, currently valued at -0.54, compared to the broader market0.002.004.006.00-0.540.75
The chart of Martin ratio for DHR, currently valued at -1.56, compared to the broader market-10.000.0010.0020.0030.00-1.562.36
DHR
ABT

The current DHR Sharpe Ratio is -0.69, which is lower than the ABT Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of DHR and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50SeptemberOctoberNovemberDecember2025February
-0.69
1.00
DHR
ABT

Dividends

DHR vs. ABT - Dividend Comparison

DHR's dividend yield for the trailing twelve months is around 0.52%, less than ABT's 1.68% yield.


TTM20242023202220212020201920182017201620152014
DHR
Danaher Corporation
0.52%0.47%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%
ABT
Abbott Laboratories
1.68%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%1.95%

Drawdowns

DHR vs. ABT - Drawdown Comparison

The maximum DHR drawdown since its inception was -65.35%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for DHR and ABT. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-28.45%
0
DHR
ABT

Volatility

DHR vs. ABT - Volatility Comparison

Danaher Corporation (DHR) has a higher volatility of 11.54% compared to Abbott Laboratories (ABT) at 7.50%. This indicates that DHR's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%SeptemberOctoberNovemberDecember2025February
11.54%
7.50%
DHR
ABT

Financials

DHR vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between Danaher Corporation and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab